Elkhorn Partners Limited Partnership Amgen Inc Transaction History

Elkhorn Partners Limited Partnership

  • $145 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$212.27 - $248.7 $42,454 - $49,740
-200 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$233.58 - $259.14 $35,037 - $38,871
150 Added 300.0%
200 $49,000
Q1 2021

May 11, 2021
BUY
$221.91 - $258.6 $11,095 - $12,930
50 New
50 $12,000

Others Institutions Holding AMGN

# of Institutions
3,075
Shares Held
417M
Call Options Held
7.19M
Put Options Held
6.28M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Elkhorn Partners Limited Partnership Portfolio

Follow Elkhorn Partners Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Elkhorn Partners Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Elkhorn Partners Limited Partnership with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email